| Literature DB >> 31268303 |
Moe Hirosawa1,2, Yoshihiko Fujita1, Hirohide Saito1.
Abstract
Anti-CRISPR proteins have the potential to regulate CRISPR-Cas systems in a cell-type-specific manner. To selectively edit the genome in target cells, we controlled the expression of AcrllA4, a Streptococcus pyogenes Cas9 inhibitor, based on endogenous microRNA (miRNA) activity. We designed a miRNA-responsive AcrllA4 switch, which is a synthetic mRNA that contains a completely complementary sequence to an arbitrary miRNA at the 5'-UTR region and encodes AcrllA4. Together with the Cas9- or dCas9-VPR-guide RNA complex, this switch functions as a cell-specific Cas9 or dCas9-VPR activator that induces gene knockout or activation depending on the target miRNA. By sensing intracellular miRNAs, the conditional CRISPR-Cas9 ON system that we report could provide a powerful tool for future therapeutic applications and genome engineering.Entities:
Keywords: CRISPR-Cas9; RNA switch; anti-CRISPR; microRNA; synthetic biology
Mesh:
Substances:
Year: 2019 PMID: 31268303 DOI: 10.1021/acssynbio.9b00073
Source DB: PubMed Journal: ACS Synth Biol ISSN: 2161-5063 Impact factor: 5.110